Foot-and Mouth Disease Ecological Studies In Endemic Settings: Ongoing Studies in Vietnam and Pakistan

Similar documents
Progressive Control of Foot and Mouth Disease in Pakistan

Progressive Control of Foot and Mouth Disease in PAKISTAN

REGIONAL REFERENCE LABORATORY FOR FMD IN SOUTH EAST ASIA DEPARTMENT OF LIVESTOCK DEVELOPMENT PAKCHONG, NAKHONRATCHASIMA, THAILAND

FMD Control in Dairy Colonies Milk Production System in Pakistan

FMD Carrier state and role of carrier buffalo as source of transboundary spread in Southeast Asia and Eastern Asia Satya Parida

Foot and Mouth Disease Status and Control Initiatives in Pakistan. Qurban Ali National Veterinary Laboratories, Islamabad

Jonathan Arzt Veterinary Medical Officer Foreign Animal Disease Research Unit ARS, USDA Plum Island Animal Disease Center

Mechanism of FMD spread in East Asia

FMD in Southern Africa

Foot and Mouth Disease Middle East situation Summary of Answers to the Questionnaire Beirut, Lebanon, 7 9 April 2009

FMD Control Initiatives in Bangladesh

FMD Vaccine Strain Selection

FMD VACCINE AND VACCINATION. Ahmad Al-Majali Dean, Faculty of Vet Medicine JUST Jordan

FMD in Libya. Dr. Abdunaser Dayhum National Center of Animal Health Libya

Toward the control of Foot-and-Mouth disease in East Asia

Dr Ghazi Yehia OIE Regional Representative for the Middle East

The early pathogenesis of FMD and the implications for control measures

Findings on FMD in Afghanistan and Pakistan

Foreign Animal Disease Research Unit USDA/ARS

National Strategies for Controlling Avian Influenza Viruses

Number of culled livestock, by species ( )

O 38% NVD 42% A 10% Asia 1 9% SAT2 1% SAT1 <1% Institute for Animal Health

Report concerning identification of the Northern European isolate of BTV (26 th August 2006)

Title of the presentation: The FMD virus. Subtitle: Virus Pool 6, Southern Africa. pools and Regional programs. Name Surname: Misheck Mulumba et al

Foot and Mouth Disease vaccination is effective: Quantification of FMD transmission with and without vaccination

Foot and mouth disease situation and control strategies in the People s Republic of China the current situation

Elements of the FMD control problem in Southern Africa: 2

16 th JPC REMESA meeting

FMD diagnostics: current developments and application in the context of FMD control in endemic countries Wilna Vosloo

Questionnaire results

PROGRESS REPORT FOR TURKEY ON FMD SITUATION AND CONTROL MEASURES

Foot and Mouth Disease Control, A vaccine perspective. John Barlow, DVM PhD

West Eurasia Regional Roadmap Meeting Country Presentation 2012

Strengthening FMD prevention and emergency response capacity in the Trans-Caucasian countries (MTF/INT/003/EEC)

Southeast Asia and China FMD Campaign

FMD Current Epidemic Situation in China

Far-East. Africa. Asia. South America. Somewhere new?

Appendix 71 Secretory IgA as an indicator of oropharyngeal FMDV replication Abstract Introduction Materials and methods

Development and Current Situation FMD for Asia and the Pacific

Field study conducted in Tunisia to evaluate efficacy of an O-BFS vaccine

Foot and mouth disease control strategies in North Africa and the Middle East the current

FAO Collaborative Study Phase XVII: Standardisation of FMD Antibody Detection

Foot-and-mouth disease virus persistence and evolution. Bryan Charleston, Pirbright Institute

EPIDEMIOLOGICAL DEVELOPMENTS AND CONTROL OF FOOT AND MOUTH DISEASE IN ASIA

Southeast Asia: Action plans, Future directions and needs

Foot and Mouth Disease Vaccine Research and Development in India

Role of the EuFMD/European countries - West EurAsia and other Regional Roadmaps

Manufacturers expected contribution to the progressive control of Foot-and-Mouth Disease in South Asia

Overview of WRL FMD. Historical perspective. Principal activities. FMD threats. Needs/prospects. David Paton

WHEN FMD GOES WILD LINKING ECOLOGY, EPIDEMIOLOGY AND SURVEILLANCE. Sergei Khomenko, Tsviatko Alexandrov, Naci Bulut, Sinan Aktas, Keith Sumption

Unique features of foot and mouth disease in Southern Africa

PRAGMATIST: A DECISION SUPPORT TOOL FOR FOOT AND MOUTH DISEASE VACCINE BANK MANAGERS

FMD risk assessment in endemic settings using value chain. Julio Pinto Animal Health Officer EMPRES/GLEWS

The Grasslands of Mongolia s Eastern Steppe. Wildlife Conservation Society

OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine OIE Paris, 6-7 April 2011

Changing landscape for livestock production and health in China and neighbouring countries; directions and implications for FMD management

And Current Situation

FMD regional update Gulf States 2017

Requirements of the Terrestrial Code for FMD surveillance. Dr David Paton Dr Gideon Brückner

FOOT AND MOUTH DISEASE DIAGNOSTICS: REQUIREMENTS FOR DEMONSTRATION OF FREEDOM FROM INFECTION

Recent FMD outbreaks and control strategy in Mongolia

OIE RRL-Lanzhou Activities, Research and Lab network

The Global control of FMD - Tools, ideas and ideals Erice, Italy October 2008 THE STATUS OF FOOT-AND-MOUTH DISEASE (FMD) IN ETHIOPIA

Preparing for the unexpected: the response to foot-and-mouth disease outbreaks in 2007 in the United Kingdom

FMD Report - Syria 6 th Regional FMD West Eurasia Roadmap Meeting - Almaty, Kazakhstan 28 to 30 April 2015

FMD Control in South East Asia: science based approach to development of roadmaps and PVS Tools to support capacity building.

Bilateral cooperation between a laboratory in Korea and laboratories in other countries:

This CRP is proposed for five years with three RCM. To apply, please see our website for directions:

Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccines

Importance of Vaccines for Managing FMD

SUMMARY REPORT. on the samples submitted by Egypt to the WRL for FMD (Pirbright Institute, UK) in 2012 & results of the tests therof

OIE/FAO Global Conference on foot and mouth disease. The way towards global control. Paraguay: 24 to 26 June Draft Resolution version 8

Appendix 72 Using NSP ELISA (Chekit-FMD-3ABC Bommeli-Intervet) as a Tool for FMDV Serosurveillance in Bulgaria Abstract: Introduction

Surveillance and early warning systems for climate sensitive diseases in Vietnam and Laos

Mandate and Activities of an OIE Reference Laboratory

THE SOUTH-EAST ASIA AND CHINA FOOT- AND-MOUTH DISEASE 2020 ROADMAP AND CONTEXT

Report on the Foot and Mouth Disease outbreak in KwaZulu Natal. 20 May 2011

Simultaneous immunization of cattle with FMD and live anthrax vaccines

The Royal Veterinary College. The Swiss Federal Veterinary Office

MAXIMISING EFFICIENCY WITH A SURVEILLANCE STRATEGY FOR FOOT-AND-MOUTH DISEASE DURING AN OUTBREAK IN A PREVIOUSLY FMD-FREE COUNTRY.

Cedivac-FMD; Duration of Immunity in cattle, sheep and pigs. 2004, 8203 AA Lelystad, The Netherlands * Corresponding Author

REPORT ON THE SITUATION OF FMD IN TURKEY

1. Engineering Foot-and-Mouth Disease Viruses with Improved

Open to: Model developers and users with an interest in the objective

GLOBAL FMD SITUATION DURING 2001/2002

WEST EURASIA FMD LAB PHASE ACTIVITY PROPOSAL. A. Naci BULUT Head of the Diagnosis Department, Şap Institute

Lelystad, The Netherlands

FMD - TURKEY. Yener ŞEKERCAN. Veterinary Officer General Directorate of Food and Control Ankara/TURKEY

FMD situation & Control Strategy in Korea

CHAPTER 7 MODELING A FMD OUTBREAK IN TULARE COUNTY

The New FMD Containment Zone Proposal and Vaccination. April 4, 2017, Pirenopolis, Brazil

Regional Status and FMD s Control Strategies in North Africa

WRLFMD: ~1000 samples from 36 countries January- December 2009 (300% up on 2008)

FAO contribution to the OFFLU swine influenza group

Syrian Arab Republic. ministry of agriculture and agrarian reform- directorate of animal health- Syria

Myanmar Disease Surveillance & Monitoring

Engineering Foot-and-Mouth Disease Virus with Improved Properties for the Development of Effective Vaccine Introduction: Materials and methods:

Support from the OIE Reference Laboratory for FMD to member countries

The work of the WRLFMD in relation to regional networks. Reference Laboratory for FMDV

in Vietnam Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control Hanoi, 2-3 October 2012

Transcription:

Foot-and Mouth Disease Ecological Studies In Endemic Settings: Ongoing Studies in Vietnam and Pakistan Luis Rodriguez (Jonathan Arzt) Research leader, USDA-ARS Plum Island 1

PAKISTAN CHARACTERIZATION OF LOCAL ISOLATES OF FMDV AND DEVELOPMENT OF VECTOR BASED VACCINES 58-1940-7-161F; 057 002S 9/1/2007-8/31/2012 REAL TIME DATA ANALYSIS AND RESEARCH CAPACITY BUILDING TOWARDS FMD CONTROL IN PAKISTAN 1940-32000-052-14S 09/27/20 12-09/27/2014 Dr. Khalid Naeem NARC Dr. Umer Farooq NARC Dr. Muhammadimam Afzal, FAO Dr. Manzoor Hussain, NVL Dr. Zaheer Ahmed Dr. Anna Ludi

Study Design Acute Clinical Samples Clinical case reports, geographic location, demographics, etc Clinical samples, viruses, sequence Longitudinal Field Study Population: buffalo premises all located near Islamabad Serological survey of 40 farms for NSP positive animals, probang, history Selection of 29 farms (300 buffalo) for sampling (serum and probang) 4X year for 1 year NSP-ELISA, RT-PCR and virus isolation Establish panel of reference sera for in country vaccine evaluation Vaccination of 10 cattle and 10 buffalo with commercial vaccine to be used in field Serum collection at 0, 21 dpv, boost vaccination Serum collection at 42 dpv Carry out vaccine matching studies

Significant amino acid and nucleotide variation, wide spatial distribution of genetic lineages, no with differences in host species, all consistent with frequent multispecies infection of this serotype O FMDV in a highly mobile population

Obtained multiple viral strains from persistent buffalo opportunity to look mechanism of strain emergence 8 /22 Animals 2 viruses of same serotype isolated at different sampling time points from same animal [8x2=16 viruses] ASIA 1 = 14 O = 2 TOTAL = 16 22/51 Animals VI positive 2 or more times, yielding 47 virus isolates 3/22 Animals 3 viruses of same serotype isolated from each Id at different sampling time points [3x3=9 viruses isolated] 9/22 Animals 2 viruses of 2 different serotypes isolated from each animal at different sampling time points [9x2=18 viruses isolated] ASIA 1 = 9 TOTAL = 9 ASIA 1/A 8X2=16 ASIA 1/O 1X2=2 TOTAL =18 1/22 Animal (3 viruses of 2 different serotypes isolated from each Id at different sampling time points) [1x3=3 viruses isolated] ASIA 1/A =3

Phylogeny of Carrier vs Clinical Serotype A Viruses Green: Carrier viruses Red: Clinical local Blue: Clinical non-local Found close relationship between persistent and acute lineages suggesting transmission Directionality of transmission not yet determined

ME-SA PanAsia PanAsia 2 Vaccine Evaluation Serotype O FMDV 82 99 Pak-O 2010, 2012, 2012 SGD/PAK/19/2011 JX170755 KHI/PAK/42/2011 JX170757 ISR/7/2007 AJ294910 OKAB/AFG/L2826/2009 HQ439234 MAY/2/2004 HQ116194 MAY/2/2006 HQ116205 PAK/39/2008 GU384685 97 99 76 PAK/63/2007 FJ798183 BAG/AFG/L1494/2009 HQ439234 MAY/11/2009 HQ116217 PAK/1/2008 FJ798190 PAK/29/2008 GU384684 CAM/1/2008 HQ116174 90 99 VIT/124/2010 VIT/169/2010 VIT/17/2005 HQ116283 80 VIT/7/2002 HQ116273 UKG/3802/2001 DQ164982*** SKR/1/2002 DQ164972 VIT/3/2005 HQ116277 82 SEA CAM-94 83 TUR/2/2001 DQ164982 80 Ankara/TUR/377/10/02 DQ296523 TUR/4/2005 FJ561321 TUR/2/2000 DQ164982 PAK/18/2002 DQ164982 99 IRN/20/2004 DQ164982 97 Mersin/TUR/13/01/04 DQ164982 IND/53/73_AF292107 O1 Manisa iso87 AY593823 Vaccine Virus representative India/R2/75 AF204276 CAM/3/98 AJ294910 Phylogeny Reconstruction Statistical Method -------------- Maximum Likelihood Test of Phylogeny --------------- Bootstrap method (500 replicates) Substitutions Type -------------- Nucleotide Model/Method ------------------ General Time Reversible model Rates among Sites --------------- Gamma distributed with Invariant sites (G+I) No of Discrete Gamma Categories - 5 ML Heuristic Method ------------- Nearest-Neighbor-Interchange (NNI) Initial Tree for ML ------------------Make initial tree automatically No. of Seqs : 33 No. of Sites : 623 *** - reference strain 0.02 8

O/ISB/255/12 O/FSD/266/12 O/JGH/6/12 O/KHI/41/11 Serotype O Vaccine Matching against O1 Manisa BT neut. r1-value BT neut. r1-value BT neut. r1-value BT neut. r1-value 2.33 1.8 0.71 2.18 1.65 0.5 2.48 1.95 1 2.25 1.95 1 1.8 1.5 0.5 2.4 1.95 0.5 1.5 1.5 0.5 2.03 1.35 0.35 1.5 1.8 1 * All values given in log 10 Conclusion: r1-values are above 0.3 suggesting the vaccine is protective against the serotype O viruses tested.

Vaccine Evaluation Serotype A FMDV 99 87 PAK/CHK/11/2012* PAK/KCH/15/2012* PUN/PAK/L1354/2009_HQ439251 PAK/76/2009_GU384686 SIN/PAK/L694/2009_HQ439247 SAR/AFG/L1435/2009_HQ439274 IRN/5/2008_FJ755068 TUR/1/2008_FJ755133 IRN/1/2005_EF208769*** vaccine virus representative PAK/1/2006_FJ755082 100 PAK/ICT/2/2008* PAK/ICT/1/2008 PAK/ICT/3/2008 PAK/KCH/5/2009* PAK/KCH/6/2009 PAK/KCH/7/2009 AFG/131/2004_EF457981 IRN/41/2003_FJ655020 PUN/PAK/L1364/2009_HQ439253 IRN/22/99_EF208772*** IRN/2/87_EF208770*** A22 Iraq64 iso86_aj251474*** vaccine virus representative 100 100 IRN/1/96_EF208771*** IRN/5/2003_FJ775018 Phylogeny Reconstruction Statistical Method -------------- Maximum Likelihood Test of Phylogeny --------------- Bootstrap method (500 rep) Substitutions Type -------------- Nucleotide Model/Method ------------------ General Time Reversible model Rates among Sites --------------- Gamma distributed with Invariant sites (G+I) No of Discrete Gamma Categories - 5 ML Heuristic Method ---------Nearest-Neighbor-Interchange (NNI) Initial Tree for ML ------------- Make initial tree automatically No. of Seqs : 24 No. of Sites : 623 *** Ref Strains * used for vaccine matching 0.05 10

A/ICT/2/2008 A/KCH/5/2009 A/CHK/11/2012 A/KCH/15/12 Serotype A Vaccine Matching against A-IRN05 and A22 IRQ BT neut. r1 A22 R1 IRN BT neut. r1 A22 r1 IRN BT neut BT neut 1.65 1.65 1.41F 1F 1.73 1.95 1.41 1 1.8 <1.2 1.95 <1.2 2.03 1.65 0.7 0.25 2.25 1.65 1.41 0.5 2.03 <1.2 2.48 <1.2 1.58 <1.2 Conclusion: * All values given in log 10 VN titers above 1.6 observed for 2008-2009 isolates VN titers below 1.2 for 2012 isolates, suggesting that the vaccine is not a good match to these strains.

VIETNAM MOLECULAR EPIDEMIOLOGY, SURVEILLANCE AND PREDICTIVE TOOLS FOR FMD CONTROL IN VIETNAM 58-1940-0-070F, 057 14S 6/1/2010-9/30/2012 Collaborators: Dr. Jonathan Arzt Dr. Helena Ferreira Dr. Thanh Long Ngo, DAH, HCMC Dr. Ho Huu Dung, DAH, Hanoi Dr. Carla Huston, Mississippi State University

Objectives 1- Molecular epidemiology of FMDV in local livestock including cattle, buffaloes and pigs 2- To better understand the transmission mechanism of persistently infected to susceptible livestock in natural setting 3- Enhance strategies for identification of persistently infected animals using new technology

Design Objective 1 Acute Clinical Samples Samples collected during outbreak Pigs, buffalo and cattle Northern and Southern Vietnam Objective 2 Longitudinal Field Study HCMC region tranmsission cells (9 farms) Hanoi-SonLa region carrier cattle and buffalo (field necropsy) Objective 3 Persistent buffalo studies Field necropsies Molecular characterization (tissue level, cytokine mrna, protein expression)

Objective 1. Phylogenetics of novel strains of FMDV Multiple lineages in multiple species no species specific lineages Novel strains (bold) found in this study

Objective 2. Ecology of FMDV carriers Two Provinces identified with history of FMD outbreaks in cattle, buffalo SonLa (north) Jan 2011 LongAn (south) Feb. 2011 Established study sites: Targeted surveillance study Buffalo necropsy study / cattle transmission study

Targeted surveillance study Risk of being FMDV infected and/or FMDV carrier: Buffalo - highest risk of being FMDV-infected, intermediate carrier risk Dairy cattle lower risk of being FMDV-infected (OR=0.2), lowest carrier risk (OR=0.2) Beef cattle - lowest risk of being FMDV-infected (OR=0.4), highest carrier risk (OR=4.9) Carrier infected : 3ABC+ and Probang +; Ever inf.: 3ABC+; Never inf. : 3ABC neg

Objective 3. Transmission Study From Carrier Cattle to Sentinel Cattle Study site in southern Vietnam no clinical activity >1yr Individual small premises - pastures, surrounding premises vaccinated bi-annually 9 farms 2 donor carrier buffalo or cattle (NSP +, Probang +) housed in direct contact with 2 naïve cattle (NSP -, Probang -) Direct contact - one year study serum and probang every 2-3 months Probang samples from naïve cattle all tested NEGATIVE for FMDV by rrt-pcr, VI Serum from naïve animals all tested for negative NSP -

Preliminary Results All donors shed virus intermittently throughout the exposure time None of the naïve cattle developed antibodies (NSP) Naïve cattle remained probang negative until the end of the study Multiple viral sequences were obtained from persistent animals

Thank you! SUPPORT: 20